Lista de obras -

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

artículo científico publicado en 2017

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

artículo científico publicado en 2020

A Common KIF6 Polymorphism Increases Vulnerability to Low-Density Lipoprotein Cholesterol: Two Meta-Analyses and a Meta-Regression Analysis ⬇️

artículo científico publicado el 21 de diciembre de 2011

A Comparison of Logistic Regression, Logic Regression, Classification Tree, and Random Forests to Identify Effective Gene-Gene and Gene-Environmental Interactions

artículo científico publicado en 2012

Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review

artículo científico publicado en 2019

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis

artículo científico publicado en 2016

Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

scientific article published on 18 September 2019

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk

artículo científico publicado en 2017

Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease

artículo científico publicado en 2019

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis

artículo científico publicado en 2018

Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease

scientific article published on 01 January 2019

Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: Results from a multi-ethnic cohort ⬇️

artículo científico publicado el 10 de enero de 2012

Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart disease.

artículo científico publicado en 2014

Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.

artículo científico publicado en 2015

Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic Studies

artículo científico publicado en 2018

Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertension

artículo científico publicado en 2014

Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis

artículo científico

Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study

artículo científico publicado en 2015

Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis

artículo científico publicado en 2020

Genetic effects on efficacy of lipid-lowering drugs

artículo científico publicado en 2017

Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?

artículo científico publicado en 2020

Homocysteine and reclassification of cardiovascular disease risk ⬇️

artículo científico publicado el 30 de agosto de 2011

How to use Mendelian randomization to anticipate the results of randomized trials

artículo científico publicado en 2017

IMPROVE-IT and genetics reaffirm the causal role of LDL in Cardiovascular Disease

artículo científico publicado en 2015

Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series

scientific article published on 01 September 2018

JCL roundtable: Lessons from genetic variants altering lipoprotein metabolism

artículo científico publicado en 2016

Lipids and Lipoproteins in 2020

artículo científico publicado en 2020

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

artículo científico publicado en 2017

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

artículo científico publicado en 2020

Mendelian Randomization Study of ACLY and Cardiovascular Disease

artículo científico publicado en 2019

Mendelian Randomization Study of ACLY and Cardiovascular Disease. Reply

scientific article published on 01 August 2020

Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps

artículo científico publicado en 2015

New prospects for PCSK9 inhibition?

artículo científico publicado en 2018

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

artículo científico publicado en 2017

Relationship of resistant hypertension and treatment outcomes with total arterial compliance in a predominantly African American hypertensive cohort

artículo científico publicado en 2012

Reply: Genetic Variation in NPC1L1 and Risk of Gallstone Disease

artículo científico publicado en 2015

Reply: To PMID 23083789

artículo científico publicado en 2013

Reprint of: Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series

scientific article published on 01 December 2018

Role of Non-High-Density Lipoprotein Cholesterol in Predicting Cerebrovascular Events in Patients Following Myocardial Infarction ⬇️

artículo científico publicado el 31 de marzo de 2012

Safety and efficacy of antihypertensive prescription at emergency department discharge

artículo científico publicado en 2015

Should African Americans Have a Lower Blood Pressure Goal than Other Ethnic Groups to Prevent Organ Damage? ⬇️

artículo científico publicado el 1 de diciembre de 2012

Should African Americans with hypertension be treated differently than non-African Americans?

artículo científico

Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension

artículo científico publicado en 2014

The Role of Early LDL Lowering to Prevent the Onset of Atherosclerotic Disease ⬇️

artículo científico publicado el 1 de abril de 2013

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society ⬇️

artículo científico publicado en 2021

Usefulness of microalbuminuria in patients with the metabolic syndrome to predict subclinical atherosclerosis and cardiovascular disease outcomes

artículo científico publicado en 2010

Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment Options

artículo científico publicado en 2018

Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension

artículo científico publicado en 2014

Vaccination to prevent atherosclerotic cardiovascular diseases

artículo científico publicado en 2017

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes

artículo científico publicado en 2016

Lista de obras de

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

A Common KIF6 Polymorphism Increases Vulnerability to Low-Density Lipoprotein Cholesterol: Two Meta-Analyses and a Meta-Regression Analysis ⬇️

A Comparison of Logistic Regression, Logic Regression, Classification Tree, and Random Forests to Identify Effective Gene-Gene and Gene-Environmental Interactions

Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis

Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk

Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis

Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease

Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: Results from a multi-ethnic cohort ⬇️

Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart disease.

Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.

Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic Studies

Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertension

Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis

Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study

Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis

Genetic effects on efficacy of lipid-lowering drugs

Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?

Homocysteine and reclassification of cardiovascular disease risk ⬇️

How to use Mendelian randomization to anticipate the results of randomized trials

IMPROVE-IT and genetics reaffirm the causal role of LDL in Cardiovascular Disease

Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series

JCL roundtable: Lessons from genetic variants altering lipoprotein metabolism

Lipids and Lipoproteins in 2020

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Mendelian Randomization Study of ACLY and Cardiovascular Disease

Mendelian Randomization Study of ACLY and Cardiovascular Disease. Reply

Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps

New prospects for PCSK9 inhibition?

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

Relationship of resistant hypertension and treatment outcomes with total arterial compliance in a predominantly African American hypertensive cohort

Reply: Genetic Variation in NPC1L1 and Risk of Gallstone Disease

Reply: To PMID 23083789

Reprint of: Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series

Role of Non-High-Density Lipoprotein Cholesterol in Predicting Cerebrovascular Events in Patients Following Myocardial Infarction ⬇️

Safety and efficacy of antihypertensive prescription at emergency department discharge

Should African Americans Have a Lower Blood Pressure Goal than Other Ethnic Groups to Prevent Organ Damage? ⬇️

Should African Americans with hypertension be treated differently than non-African Americans?

Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension

The Role of Early LDL Lowering to Prevent the Onset of Atherosclerotic Disease ⬇️

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society ⬇️

Usefulness of microalbuminuria in patients with the metabolic syndrome to predict subclinical atherosclerosis and cardiovascular disease outcomes

Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment Options

Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension

Vaccination to prevent atherosclerotic cardiovascular diseases

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes